M35.03, Sjogren syndrome with myopathyICD-10-CM
No Prior Auth Required
Covered without prior authorization by at least one policy, though another does not cover it (medium confidence)
CGS-J15-L35897, Nerve Conduction Studies and Electromyography
J15
CGS-J18-L35897, Nerve Conduction Studies and Electromyography
J18
WPS-J5-L34594, Nerve Conduction Studies and Electromyography
J5
A59434, Billing and Coding: Amniotic and Placental-Derived Product Injections and/or Applications for Musculoskeletal Indications, Non-Wound
J5
Ask Backwork about documentation requirements, denial risks, or coverage in your state.
A55639, Billing and Coding: Chemotherapy Agents for Non-Oncologic Conditions
J5
WPS-J5-L37205, Chemotherapy Drugs and their Adjuncts
J5
A57478, Billing and Coding: Nerve Conduction Studies and Electromyography
J5
A57668, Billing and Coding: Nerve Conduction Studies and Electromyography
J6
A58893, Billing and Coding: Amniotic and Placental-Derived Product Injections and/or Applications for Musculoskeletal Indications, Non-Wound
J6
NGS-J6-L35098, Nerve Conduction Studies and Electromyography
J6
NGS-J6-L39297, Off-label Use of Rituximab and Rituximab Biosimilars
J6
A59101, Billing and Coding: Off-label Use of Rituximab and Rituximab Biosimilars
J6
WPS-J8-L37205, Chemotherapy Drugs and their Adjuncts
J8
WPS-J8-L34594, Nerve Conduction Studies and Electromyography
J8
FIRST_COAST-L34021, Sedimentation Rate, Erythrocyte
J9
A57123, Billing and Coding: Nerve Conduction Studies and Electromyography
J9
A57657, Billing and Coding: Sedimentation Rate, Erythrocyte
J9
FIRST_COAST-L34859, Nerve Conduction Studies and Electromyography
J9
A59764, Billing and Coding: Amniotic and Placental-Derived Product Injections and/or Applications for Musculoskeletal Indications, Non-Wound
J9
NOVITAS-JH-L35081, Nerve Conduction Studies and Electromyography
JH